Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Compensation??

<< Previous

Bullboard Posts

Next >>

Comment by juniper88on Aug 22, 2022 11:18pm

167 Views

Post# 34913177

RE:RE:Compensation??

My wife got about 70 USD for each visit. It is supposed to help pay for transportation, parking, etc. Thera paid a flat fee. The immunotherapy trial my wife was on paid by the mile you traveled. Although, different sponsors do it differently I was told that pretty much all the sponsors compensate the patients in some way. Nothing unusual.

PWIB123 wrote: Is it normal to compensate? I guess you could take that two ways. Either they are having trouble recruiting or they are trying to recruit even faster.

scarlet1967 wrote: https://www.ziprecruiter.com/c/Mary-Crowley-Cancer-Research/Job/Compensated-Clinical-Trial-Examining-TH1902-for-Prostate-Cancer/-in-Los-Angeles,CA?jid=f83aa6d28e71fdf2&lvk=Du5FfjiRhW0rphkJ_YOcrw.--MaohABGcV